ICM
About:
ICM develops a gene theraphy aimed to combat osteoarthritis and age-related mascular disease.
Top Investors: Stonebridge Capital
Description:
Total Funding Amount:
2B KRW
Headquarters Location:
California, Maryland, United States
Founded Date:
1954-01-01
Founders:
Number of Employees:
501-1000
Last Funding Date:
2017-06-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai